| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1027 | 721 | 30 |
| Full Text Views | 10 | 3 | 2 |
| PDF Downloads | 12 | 4 | 2 |
In Vitro Antimalarial Activity of Tetrahydrofolate Dehydrogenase Inhibitors
David G. Sixsmith
David G. Sixsmith
Clinical Research Centre, Kenya Medical Research Institute, Pharmacy Department, University of Nairobi, U.S. Army Medical Research Unit—Kenya, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, P.O. Box 20778, Nairobi, Kenya
Search for other papers by David G. Sixsmith in
Current site
Google Scholar
PubMed
Search for other papers by David G. Sixsmith in
Current site
Google Scholar
PubMed
William M. Watkins
William M. Watkins
Clinical Research Centre, Kenya Medical Research Institute, Pharmacy Department, University of Nairobi, U.S. Army Medical Research Unit—Kenya, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, P.O. Box 20778, Nairobi, Kenya
Search for other papers by William M. Watkins in
Current site
Google Scholar
PubMed
Search for other papers by William M. Watkins in
Current site
Google Scholar
PubMed
Jeffrey D. Chulay
Jeffrey D. Chulay
Clinical Research Centre, Kenya Medical Research Institute, Pharmacy Department, University of Nairobi, U.S. Army Medical Research Unit—Kenya, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, P.O. Box 20778, Nairobi, Kenya
Search for other papers by Jeffrey D. Chulay in
Current site
Google Scholar
PubMed
Search for other papers by Jeffrey D. Chulay in
Current site
Google Scholar
PubMed
Harrison C. Spencer
Harrison C. Spencer
Clinical Research Centre, Kenya Medical Research Institute, Pharmacy Department, University of Nairobi, U.S. Army Medical Research Unit—Kenya, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, P.O. Box 20778, Nairobi, Kenya
Search for other papers by Harrison C. Spencer in
Current site
Google Scholar
PubMed
Search for other papers by Harrison C. Spencer in
Current site
Google Scholar
PubMed
Three tetrahydrofolate dehydrogenase (dihydrofolate reductase = EC 1.5.1.3) inhibitors were tested for antimalarial activity against Plasmodium falciparum, using an in vitro radioisotopic technique. Activity of each drug was tested in both normal RPMI medium 1640 and in modified medium (containing no p-aminobenzoic acid and 2.27 × 10-8 M folic acid) after a 24- or 48-hour exposure. Activity was increased 20- to 85-fold using the modified medium and the longer exposure time. Under all conditions, pyrimethamine and cycloguanil were of equal or greater potency than an experimental pyrimethamine analogue, M&B 35769, against pyrimethamine-sensitive strains, but M&B 35769 was more active than either pyrimethamine or cycloguanil against pyrimethamine-resistant strains.
Author Notes
Present address: Department of Immunology, Walter Reed Army Institute of Research, Washington, D.C. 20307.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1027 | 721 | 30 |
| Full Text Views | 10 | 3 | 2 |
| PDF Downloads | 12 | 4 | 2 |